Bocouture 50iu x 2 Vials

Bocouture is a toxin, classed as a  prescription only medicine that is indicated for the temporary improvement in the appearance of moderate to severe lines in adult patients under 65 years.

Key Features:

• Botulinum neurotoxin type A blocks cholinergic transmission at the neuromuscular junction by inhibiting the release of acetylcholine.
• Bocouture is free from complexing proteins

Treatment Areas:

• Glabellar frown lines
• Periorbital lines
• Horizontal forehead lines

Mode of action:

• Botulinum neurotoxin type A blocks cholinergic transmission at the neuromuscular junction by inhibiting the release of acetylcholine.
• The nerve terminals of the neuromuscular junction no longer respond to nerve impulses, and secretion of the neurotransmitter at the motor endplates is prevented.
• The action results in stopping the muscular contraction of the targeted muscles.

Contraindications of Bocouture:

• Hypersensitivity to the active substance or to any of the excipients.
• Generalised disorders of muscle activity (e.g. myasthenia gravis, Lambert- Eaton syndrome).
• Infection or inflammation at the proposed injection site.

Who should not use Bocouture?

• The injection of Bocouture is not recommended for patients with a history of aspiration or dysphagia.
• Patients suffering from amyotrophic lateral sclerosis
• Patients with other diseases which result in peripheral neuromuscular dysfunction
• In targeted muscles that display pronounced weakness or atrophy

Patient Information Leaflet: https://www.medicines.org.uk/emc/files/pil.600.pdf

Shop the full Bocouture range at Fox Pharma.